Cart
sales@molnova.com
Home - Products - Endocrinology/Hormones - Opioid Receptor - Trimebutine

Trimebutine

CAS No. 39133-31-8

Trimebutine( —— )

Catalog No. M14347 CAS No. 39133-31-8

Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
500MG 37 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Trimebutine
  • Note
    Research use only, not for human use.
  • Brief Description
    Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.
  • Description
    Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    39133-31-8
  • Formula Weight
    387.47
  • Molecular Formula
    C22H29NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 50 mg/mL (129.04 mM)
  • SMILES
    CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Prescrire Int. 2013 Oct;22(142):241-2.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Hemorphin-7

    Hemorphin-7 binds to the angiotensin IV receptor, triggering multiple effects including cellular proliferation and memory enhancement. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. Hemorphin-7 is investigated as a potential biomarker for breast cancer.

  • ML-184

    ML-184 is a potent synthetic agonist of GPR55 with EC50 of 0.26 μM.

  • CTAP(TFA）

    CTAP TFA is a potent, highly selective, and brain penetrant ?antagonist of μ-opioid receptor with IC50 of 3.5 nM.?It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors.

Sign In Join Free